Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors

This is a Phase 1 study evaluating the feasibility of using SLR-108 for positron-emission tomography (PET) imaging of metastatic solid tumors.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Solve TherapeuticsUpdated: Aug 10, 2026Locations: 1
Eligibility criteria

Men or women (as appropriate for cancer type) of age ≥18 years. [+17]

Malignancy involving the central nervous system unless brain metastases have bee... [+11]

Read more
Status: Recruiting

SLV-154 Treatment of Advanced Cancers

This is a Phase 1 study comprising a Phase 1a dose-escalation portion and a Phase 1b expansion portion evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with advanced solid tumors.

Participants needed: 250
Trial details
Phase: Phase 1Age: 12+Biological sex: AllType: InterventionalSponsor: Solve TherapeuticsUpdated: Jul 24, 2026Locations: 10
Eligibility criteria

Men or women (as appropriate for cancer type) of age ≥12 years. [+18]

Unstable malignancy involving the central nervous system. [+9]

Read more
Status: Recruiting

SLV-324 Treatment of Metastatic Solid Tumors

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-324 across a range of dose levels when administered to subjects with metastatic solid tumors.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Solve TherapeuticsUpdated: Feb 23, 2026Locations: 7
Eligibility criteria

Men or women (as appropriate for cancer type) of age ≥18 years. [+18]

Malignancy involving the central nervous system unless brain metastases have bee... [+10]

Read more